EU: Checklist for Brexit Preparation
Recommendation

17/18 June 2026
Copenhagen, Denmark
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
The end of the transition period is approaching and no agreement is in sight. Having first published a Communication to prepare for the end of the transition period, the European Commission has now published a respective 'Brexit Readiness Checklist' for companies doing business with the UK. This checklist is designed to help EU companies doing business in the UK (United Kingdom; UK) and/or UK companies doing business in the EU to check exactly how well prepared they are for 1 January 2021.
Some of the key points are:
- Companies should familiarise themselves with the obligations of an exporter or importer in relation to trade with third countries.
- Accordingly, companies should inform themselves about relevant EU customs formalities.
- In future, companies should provide proof of the originating status of goods (this also applies to the corresponding supplier declarations).
- Certificates and approvals from a UK authority or body must be transferred to an EU authority/body. New certificates or approvals may have to be applied for. Products certified only by UK-based authorities/bodies may no longer be placed on the EU market.
- As EU REACH regulation (Registration, Evaluation, Authorisation and Restriction of Chemicals) will no longer apply in the UK, companies must ensure that substances are registered with a manufacturer or importer in the EU.
Related GMP News
29.05.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated
01.04.2026New EMA GMP Guidelines in the next three Years
01.04.2026New EMA Guidance: Risk Management for Elemental Impurities in Veterinary Medicinal Products
18.03.2026Sampling in the Focus of the FDA
11.03.2026EU Pharma Package: Final Texts officially published


